How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control

Autor: Verver, S, Walker, M, Kim, Y E, Fobi, G, Tekle, A H, Zouré, H G M, Wanji, S, Boakye, D A, Kuesel, A C, De Vlas, S J, Boussinesq, M, Basáñez, M-G, Stolk, W A

Publikováno v: S274
S267
Clinical Infectious Diseases, 66, S267-S274. Oxford University Press
Clinical infectious diseases, 66, S267-S274. Oxford University Press
CLINICAL INFECTIOUS DISEASES

Background. Great strides have been made toward onchocerciasis elimination by mass drug administration (MDA) of ivermectin. Focusing on MDA-eligible areas, we investigated where the elimination goal can be achieved by 2025 by continuation of current

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a9f0fb5665fae3b6f69032e215e13460
http://hdl.handle.net/10044/1/55864

African Programme for Onchocerciasis Control: Ophthalmological Findings in Bushenyi, Uganda

Autor: Babalola, OE, Ogbuagu, FK, Maegga, BTA, Braide, EI, Magimbi, C, Ekpo, UF, Zouré, H, Yaméogo, L, Sékétéli, A

Publikováno v: West African Journal of Medicine; Vol 30, No 2 (2011); 104-109

Background: The overall prevalence of blindness from Onchoceriasis in Bushenyi is relatively low, most of which is to be found in the elderly. Onchoceriasis is a major health problem in Africa. The Community-Directed treatment with invermectin is a c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::3c590316295f70024527343660f2bcdf
https://www.ajol.info/index.php/wajm/article/view/77413

Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.

Autor: Makenga Bof, J-C, Maketa, V, Bakajika, D K, Ntumba, F, Mpunga, D, Murdoch, M E, Hopkins, A, Noma, M M, Zouré, H, Tekle, A H, Katabarwa, M N, Lutumba, P

Publikováno v: Tropical Medicine & International Health; Jan2015, Vol. 20 Issue 1, p48-62, 15p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.